AUTHOR GUIDELINES

Information About Journal
The New Journal of Urology (New J Urol) is the journal published by Eurasian Urooncological Association. The New Journal of Urology is an international, scientific, open access, online/published journal in accordance with independent, unbiased, and double-blinded peer-review principles, published three times a year on February, June and October. New J Urol is indexing in both international and national indexes and the publication language is English. New J Urol is indexing in both international and national indexes; TR Dizin (ULAKBİM), Google Schoolar, Türk Medline Pleksus, Türkiye Atıf Dizini, SOBIAD, OAJI, İdeal Online, EuroPub, J-GATE, DOAJ, EBSCO and InfoBase Index.

The New Journal of Urology publishes papers on all aspects of urology and related topics. In addition to original articles, review articles, case reports and letters to the editor are also published. The scientific board guiding the selection of the papers to be published in the journal consists of elected experts of the journal and if necessary, are selected from national and international authorities.

The authors should guarantee that the manuscripts have not been previously published and/or are under consideration for publication elsewhere. Only those data presented at scientific meetings in form of an abstract may be accepted for consideration, however, the date, name and place of the meeting in which the paper was presented should be stated. The signed statement of scientific contributions and responsibilities of all authors, and statement on the absence of conflict of interests are required. All manuscripts are reviewed by the editor and at least two experts/reviewers. The authors of the accepted for publication manuscripts should agree that the editor can make corrections on the condition that there are no changes in the main text of the paper. Manuscript format should be in accordance with Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (available at http://www.icmje.org/). The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing.
The New Journal of Urology does not charge any article submission or processing fee.
All submissions are screened by a similarity detection software (iThenticate by Crossref). In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.
As of 2021, only articles in English will be considered for publication.
The authors should identify the individuals who accept direct responsibility for the manuscript. Each individual listed as an author should fully meet the criteria for authorship and should complete an authorship form (criteria recommended by the International Committee of Medical Journal Editors - www.icmje.org/). The corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Authors' credentials and e-mail addresses are in no way used for other purposes. The journal will allow the authors to retain publishing rights without restrictions.
When using previously published content, including figures, tables, or any other material in electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).
Statements or opinions expressed in the manuscripts published in The New Journal of Urology reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility regarding the published content rests with the authors.

General Guidelines
Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at https://dergipark.org.tr/en/yud. Manuscripts submitted via any other medium will not be evaluated. Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests. The editor reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. Editors have the right to make corrections without changing the main text.

The ORCID (Open Researcher and Contributor ID) number of the authors should be provided while sending the manuscript. A free registration can be done at http://orcid.org.

For the experimental, clinical and drug studies having the obligation of being approved by ethical committee and being sent to be published in The New Journal of Urology, ethical committee approval report being in accordance with the international agreements is required (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). In experimental animal studies, the authors should indicate that the procedures followed were in accordance with animal rights ("Guide for the Care and Use of Laboratory Animals" https://oacu.oir.nih.gov/regulations-standards) and they should obtain animal ethics committee approval. The approval of the ethical committee including the approval number and the fact that the “informed consent” is given by the patients should be indicated in the “Methods” section. Authors should declare the conflict of interest concerning their articles and the financial supports.
The rules for the title page, references, figures and tables are valid for all types of articles published in this journal.

Authors are required to submit the following:
• Author Contribution&Copyright Transfer Form
• Informed Consent Form
• ICMJE Disclosure of Interest
• Title Page
• Main document
• Figures
• Tables

PREPARATION OF MANUSCRIPT
Title Page
A separate title page should include the full title of the manuscript, running title, author’s name, affiliations, ORCID ID of authors, corresponding author’s contact information. The author to whom correspondence will be addressed should be indicated (email address, address, telephone and fax numbers).
If the content of the paper has been presented before, and if the summary has been published, the time and place of the conference should be denoted on this page.
If any grants or other financial support has been given by any institutions or firms for the study, information must be provided by the authors.
Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria should be included.

Main Document
The articles should be written with double-spaced in 12-point, Times New Roman character and at least 2.5 cm from all edges of each page. The main text should not contain any information about the authors' names and affiliations. On the first page (both Turkish and English) title, abstract and keywords should be given.

Abstract
Original articles should have a structured English (Objective, Material and Methods, Results, Conclusion) and Turkish (Amaç, Gereç ve Yöntemler, Bulgular, Sonuç) abstract. Review articles and case reports should have an unstructured abstract. Articles and abstracts should be written in accordance with the word limits specified in the table. References, tables and citations should not be used in an abstract.

Keywords
Authors must include relevant keywords (3-6) on the line following the end of the abstract The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).

For the international authors, submission of Turkish title, Turkish abstracts and Turkish keywords are not required. These will be provided by the editorial office.

Manuscript
All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be explained clearly in parentheses following the definition and custom abbreviations should not be used.
Statistical analysis is usually necessary to support results in original articles. Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified.
Whenever a product, software, or software program is mentioned in the main text, product information (including state in the USA) must be given in parentheses, including the product name, product manufacturer, city of production, and country of the company.
Limitations, drawbacks, and the shortcomings of original articles should be mentioned in the discussion section before the conclusion paragraph.
Reviews prepared by authors who have extensive knowledge on a particular field and whose scientific background has been translated into a high volume of publications with a high citation potential are welcomed. These authors may even be invited by the journal. Reviews should describe, discuss, and evaluate the current level of knowledge of a topic in clinical practice and should guide future studies.
Letter to the Editor discusses important parts, overlooked aspects, or lacking parts of a previously published article. Articles on subjects within the scope of the journal that might attract the readers’ attention, particularly educative cases, may also be submitted in the form of a “Letter to the Editor.” Readers can also present their comments on the published manuscripts in the form of a “Letter to the Editor.” The text should be unstructured.
All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. The symbols used must be nomenclature used standards.
All pages of the manuscript should be numbered at the bottom center, except for the title page. Papers should include the necessary number of tables and figures to provide better understanding.

Limitations for each manuscript type

Original Research Articles should include subheadings below;
• Title (both Turkish and English)
• Abstract (both Turkish and English)
• Keywords (both Turkish and English)
• Introduction
• Material and Methods
• Results
• Discussion
• Conclusions
• Figures and Tables Legend
• References

Case Reports should include subheadings below;
• Title (both Turkish and English)
• Abstract (unstructured, both Turkish and English)
• Keywords (both Turkish and English)
• Introduction
• Case Presentation
• Discussion and Conclusion
• Figures and Tables Legend
• References

Review Article should include subheadings below;
• Title (both Turkish and English)
• Abstract (unstructured, both Turkish and English)
• Keywords (both Turkish and English)
• Main text
• Conclusion
• Figures and Tables Legend
• References
For systematic reviews, authors must adhere to the PRISMA guidelines (http://www.prisma-statement.org/documents/PRISMA%202009%20checklist.pdf).

Letters to Editor should include subheadings below;
• Title
• Keywords
• Main text
• Figures and Table Legend
• References

Figures and Tables
Figures, graphics, and photographs should be submitted as separate files (in JPEG format) through the submission system.
The files should not be embedded in a Word file of the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system.
Images should be numbered by Arabic numbers to indicate figure subunits.
Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends.
The minimum resolution of each submitted figure should be 300 DPI.
Figures or illustrations must not permit the identification of patients and written informed consent for publication must be sought for any photograph.
Figure legends should be listed at the end of the main document.

Tables should embed in the main document or should be submitted as separate files but if tables are submitted separately please note where it is suitable in the main text. All tables should be numbered consecutively in the order they are used to within the main text. Tables legends should be listed at the end of the main document.

References
While citing publications, preference should be given to the latest, most up-to-date publications. Authors should avoid using references that are older than ten years. The references used in the article must be written in parenthesis, at the end of the sentences. References should be numbered in the order they appear in the text and listed in the same order in which they are cited in the text. Be consistent with your referencing style across the document.
References must contain surnames and initials of all authors, article title, name of the journal, the year, and the first and last page numbers. If there are more than 6 authors, an abbreviation of “et al.” should be used for the authors out of the first three. Journal titles should be abbreviated according to Index Medicus.
You must add the DOI (Digital object identifier) at end of each reference.
For Examples
Article in journal: Tasci A, Tugcu V, Ozbay B, et al. Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. J Endourol. 2009;23:1879-1881. 
For Books: Günalp İ. Modern Üroloji. Ankara: Yargıçoğlu Matbaası, 1975.
Chapters in books: Anderson JL, Muhlestein JB. Extra corporeal ureteric stenting during laparoscopic pyeloplasty. Philadelphia: W.B. Saunders, 2003; p. 288-307.
For website; Gaudin S. How moon landing changed technology history [serial online]. 2009 [cited 2014 June 15]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/
For conference proceeding; Anderson JC. Current status of chorion villus biopsy. Paper presented at: APSB 1986. Proceedings of the 4th Congress of the Australian Perinatal Society, Mothers and Babies; 1986 Sep 8-10; Queensland, Australian. Berlin: Springer; 1986. p. 182-191.
For Thesis; Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Süleyman Demirel Üniversitesi Tıp Fakültesi Spor Hekimliği Anabilim Dalı Uzmanlık Tezi. Isparta: Süleyman Demirel Üniversitesi; 2016.

Author Contribution&Copyright Transfer Form
The New Journal of Urology requires corresponding authors to submit a signed and scanned version of the authorship contribution form (available for download through https://dergipark.org.tr/tr/journal/1455/file/2260/download) during the initial submission process to act appropriately on authorship rights and to prevent ghost or honorary authorship.

Manuscript Retraction: For any other reason authors may withdraw their manuscript from the journal with a written declaration.

Revisions
When submitting a revised version of a paper, the author must submit a detailed “Response to the reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial period is over.

AFTER ACCEPTANCE
Accepted manuscripts are copy-edited for grammar, punctuation, and format. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested. The journal owner and the editorial board are authorized to decide in which volume of the accepted article will be printed. Authors may publish their articles on their personal or corporate websites by linking them to the appropriate cite and library rules.

Instructions for authors are shaped on the recommendations of International Committee of Medical Journal Editors
The Editorial Board Members of the Journal accept to follow 'Editorial Policy' of the 'Council of Science Editors' and the guidelines provided by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.

Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.

An approval of research protocols by the Ethics Committee in accordance with international agreements World Medical Association Declaration of Helsinki is required for experimental, clinical, and drug studies and for some case reports. If required, ethics committee reports or an equivalent official document will be requested from the authors.
If there is any concern or dispute at over the stıdies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.